Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Quest Diagnostics and Natera have announced that Quest Diagnostics will offer physicians access to Panorama, a new non-invasive prenatal test developed by Natera.
Subscribe to our email newsletter
The test will be made available to physician clients of Quest Diagnostics in certain regions in the US in March and available nationwide from April 2013.
Panorama is a non-invasive screening test, which can be used at the stage of early ninth week of pregnancy, and provides early information for assessing pregnancy risks.
Panorama uses cell-free fetal DNA in circulating maternal blood to screen for chromosomal abnormalities associated with trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), trisomy 13 (Patau syndrome) and monosomy X (Turner syndrome).
Quest Diagnostics Nichols Institute genetics division senior medical director Charles Strom said Cell-free fetal DNA testing is a major advancement in prenatal screening.
"By offering physicians and women access to Panorama, Quest Diagnostics is delivering on its commitment to provide clinically important innovations aligned with guideline-based care," Strom added.